Strategies for Successful Long-Term Engagement of Adults With Phenylalanine Hydroxylase Deficiency Returning to the Clinic
Authors:
Open Access
- 1 January 2017
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Journal of Inborn Errors of Metabolism and Screening
- Vol. 5
Abstract
Nearly half of all patients diagnosed with phenylalanine hydroxylase (PAH) deficiency, also known as phenylketonuria, are lost to follow-up (LTFU); most are adults who stopped attending clinic after the age of 18 years. To understand why adult patients with PAH deficiency disengage from their clinic, a focus group of 8 adults with PAH deficiency who had been LTFU for 2 or more years was held in March 2016. Ten clinicians observed the focus group and discussed strategies for successfully reengaging adult patients and encouraging lifelong management of PAH deficiency. Four strategies were proposed: (1) create a safe, supportive environment, (2) acknowledge patients as partners in their care, (3) develop individualized management plans, and (4) provide patients with additional resources. These strategies provide a framework to motivate change in clinical practice to meet the unique needs of adults with PAH deficiency.Keywords
Funding Information
- BioMarin Pharmaceutical
This publication has 37 references indexed in Scilit:
- The Process of Patient Empowerment in Integrative Health Coaching: How does it Happen?Global Advances in Health and Medicine, 2013
- Psychiatric symptoms in adults with phenylketonuriaMolecular Genetics and Metabolism, 2013
- Follow up of phenylketonuria patientsMolecular Genetics and Metabolism, 2011
- High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double‐blind, placebo‐controlled, crossover trialJournal of Inherited Metabolic Disease, 2010
- Reaching out to the lost generation of adults with early-treated phenylketonuria (PKU)Molecular Genetics and Metabolism, 2010
- The reality of dietary compliance in the management of phenylketonuriaJournal of Inherited Metabolic Disease, 2010
- Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU)Health and Quality of Life Outcomes, 2008
- Optimal management of phenylketonuria: A centralized expert team is more successful than a decentralized model of careThe Journal of Pediatrics, 2004
- Living with phenylketonuria: Perspectives of patients and their familiesJournal of Inherited Metabolic Disease, 2004
- Agoraphobia in phenylketonuriaJournal of Inherited Metabolic Disease, 1990